YZ

Yehuda Zelig

Director Director DIN 00989152
DIN 00989152 First appointment May 2007 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2007
Shareholding value Locked Premium profile

About Yehuda Zelig

Data last updated:

Yehuda Zelig has 19 years in corporate governance. Formerly with 1 company, such as M. J. Biopharm Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00989152
Primary Designation Director
First Appointment 15 May 2007
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
M. J. Biopharm Private Limited U24234PN2002PTC158855
Director15 May 20072002Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
M. J. Biopharm Private Limited
Premium access

Shareholding and investment profile for Yehuda Zelig

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yehuda Zelig

Yehuda Zelig has 19 years in corporate governance. Formerly with 1 company, such as M. J. Biopharm Private Limited. Engaged in General Business. Contributes to corporate operations.

Yehuda Zelig is associated with 0 companies as a director.

Yehuda Zelig has expertise in General Business.

Yehuda Zelig has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available